These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22319541)
1. Infection by CXCR4-Tropic Human Immunodeficiency Virus Type 1 Is Inhibited by the Cationic Cell-Penetrating Peptide Derived from HIV-1 Tat. Keogan S; Passic S; Krebs FC Int J Pept; 2012; 2012():349427. PubMed ID: 22319541 [TBL] [Abstract][Full Text] [Related]
2. The cationic cell-penetrating peptide CPP(TAT) derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts: optical, biophysical, and metabolic evidence. Ziegler A; Nervi P; Dürrenberger M; Seelig J Biochemistry; 2005 Jan; 44(1):138-48. PubMed ID: 15628854 [TBL] [Abstract][Full Text] [Related]
3. Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells. Turner JJ; Ivanova GD; Verbeure B; Williams D; Arzumanov AA; Abes S; Lebleu B; Gait MJ Nucleic Acids Res; 2005; 33(21):6837-49. PubMed ID: 16321967 [TBL] [Abstract][Full Text] [Related]
4. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake. Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438 [TBL] [Abstract][Full Text] [Related]
6. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. Kardani K; Bolhassani A PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823 [TBL] [Abstract][Full Text] [Related]
7. Cell-Surface Interactions on Arginine-Rich Cell-Penetrating Peptides Allow for Multiplex Modes of Internalization. Futaki S; Nakase I Acc Chem Res; 2017 Oct; 50(10):2449-2456. PubMed ID: 28910080 [TBL] [Abstract][Full Text] [Related]
8. Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions. Mishra A; Lai GH; Schmidt NW; Sun VZ; Rodriguez AR; Tong R; Tang L; Cheng J; Deming TJ; Kamei DT; Wong GC Proc Natl Acad Sci U S A; 2011 Oct; 108(41):16883-8. PubMed ID: 21969533 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs. Kashanchi F; Sadaie MR; Brady JN Virology; 1997 Jan; 227(2):431-8. PubMed ID: 9018142 [TBL] [Abstract][Full Text] [Related]
10. Impact of cell-penetrating peptides (CPPs) melittin and Hiv-1 Tat on the enterocyte brush border using a mucosal explant system. Danielsen EM; Hansen GH Biochim Biophys Acta Biomembr; 2018 Aug; 1860(8):1589-1599. PubMed ID: 29856994 [TBL] [Abstract][Full Text] [Related]
11. Conjugation of a Cationic Cell-Penetrating Peptide with a Novel Kunitzin-like Trypsin Inhibitor: New Insights for Enhancement of Peptide Bioactivities. Yao J; Yin W; Chen Y; Chen X; Jiang Y; Wang T; Ma C; Zhou M; Chen T; Shaw C; Wang L Pharmaceutics; 2022 Aug; 14(9):. PubMed ID: 36145553 [TBL] [Abstract][Full Text] [Related]
12. Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide. Zou L; Peng Q; Wang P; Zhou B J Membr Biol; 2017 Apr; 250(2):115-122. PubMed ID: 27933338 [TBL] [Abstract][Full Text] [Related]
13. Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. Moutal A; François-Moutal L; Brittain JM; Khanna M; Khanna R Front Cell Neurosci; 2014; 8():471. PubMed ID: 25674050 [TBL] [Abstract][Full Text] [Related]
14. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. Vivès E; Brodin P; Lebleu B J Biol Chem; 1997 Jun; 272(25):16010-7. PubMed ID: 9188504 [TBL] [Abstract][Full Text] [Related]
15. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains. Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440 [TBL] [Abstract][Full Text] [Related]
16. Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Silhol M; Tyagi M; Giacca M; Lebleu B; Vivès E Eur J Biochem; 2002 Jan; 269(2):494-501. PubMed ID: 11856307 [TBL] [Abstract][Full Text] [Related]
18. Potent Antibacterial Activity of Synthetic Peptides Designed from Salusin-β and HIV-1 Tat(49-57). Kimura M; Kosuge K; Ko Y; Kurosaki N; Tagawa N; Kato I; Uchida Y Chem Pharm Bull (Tokyo); 2020 Aug; 68(8):810-813. PubMed ID: 32448814 [TBL] [Abstract][Full Text] [Related]
19. Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides. Devadas K; Boykins RA; Hardegen NJ; Philp D; Kleinman HK; Osa EO; Wang J; Clouse KA; Wahl LM; Hewlett IK; Rappaport J; Yamada KM; Dhawan S Peptides; 2006 Apr; 27(4):611-21. PubMed ID: 16256245 [TBL] [Abstract][Full Text] [Related]
20. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT. Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]